Sanofi Portfolio Stock Holdings
According to the SEC 13F filed on July 28, 2026, Sanofi disclosed 10 stock positions valued at approximately $534.04M as of quarter-end June 30, 2026. The largest holdings include MeiraGTx Holdings plc, Inhibrx Biosciences, Inc., and Novavax.
- Report Period
- June 30, 2026
- No. of Stocks
- 10
- Portfolio Value
- $534.04M
Holdings by Sector
Sanofi Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| MeiraGTx Holdings plc | MGTX | Other | 30.86% | 12,197,737 | - | - | $164,791,427 |
| Inhibrx Biosciences, Inc. | INBX | Healthcare | 20.54% | 1,157,926 | - | - | $109,713,489 |
| Novavax | NVAX | Healthcare | 12.14% | 6,880,481 | - | - | $64,814,131 |
| AnaptysBio | ANAB | Healthcare | 10.39% | 821,917 | - | - | $55,479,398 |
| Odyssey Therapeutics Inc. | ODTX | Other | 6.98% | 1,991,918 | +1,991,918 | +100.00% | $37,268,786 |
| Agomab Therapeutics NV | AGMB | Other | 6.76% | 2,783,096 | - | - | $36,124,586 |
| MapLight Therapeutics Inc. | MPLT | Other | 6.12% | 912,041 | - | - | $32,687,549 |
| First Tracks Biotherapeutics Inc. | TRAX | Other | 3.10% | 821,917 | +821,917 | +100.00% | $16,536,970 |
| Immuneering Corp | IMRX | Healthcare | 2.53% | 2,708,559 | - | - | $13,515,709 |
| Q32 Bio Inc. | QTTB | Healthcare | 0.58% | 244,083 | - | - | $3,109,617 |
Showing 10 of 10 holdings in the latest reporting period.